In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clorox Pays $290M To Digest Entry Into Probiotics With Renew Life

This article was originally published in The Tan Sheet

Executive Summary

Clorox Co. enters the probiotics space with a $290m purchase of Renew Life, a firm with annual sales of $115m. Clorox plans to expand the firm's lines in the natural product and mass retail markets while targeting new points of sale.

You may also be interested in...



Clorox Did Homework On Becoming 'Emerging' Supplements Leader Before Buying Nutranext

“We love that we’re in differentiated segments here, emerging segments, not single letter vitamins, but product benefits that are scientifically grounded and that start to have a really strong following among consumers,” Clorox CEO Bennor Dorer says of the firm's recent Nutranext acquisition. He explained the “rationale” for buying a business that competes in a “fragmented category” without a brand leader during Clorox' third-quarter earnings briefing.

Clorox Acts On Tax Reform Excitement With Nutritional Sector Acquisition

Clorox is acquiring Nutranext, manufacturer and marketer of dietary supplement brands including Rainbow Light and Natural Vitality, a month after executives said during the firm's latest earnings briefing that US tax code change, particularly eliminating taxing income earned in foreign markets when it is transferred to the US, heightens their interest in mergers and acquisitions. Expect more from Clorox and in the broader health care space, says analysts.

Supplement Industry Investment Continues On Swander Pace Contract Manufacturing Move

Swander Pace expands Captek’s operations less than two years after acquiring the firm and seven months after investing in a protein supplement manufacturer as one of numerous private equity firms active in the nutritional products space.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel